Alnylam Pharmace. buy Stifel Nicolaus
Start price
14.09.23
/
50%
€181.40
Target price
14.09.24
€225.00
Performance (%)
32.41%
End price
15.09.24
€240.20
Summary
This prediction ended on 15.09.24 with a price of €240.20. With a performance of 32.41% the BUY prediction by Stifel_Nicolaus was a big success. Stifel_Nicolaus has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Stifel_Nicolaus has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 7.946% | 7.946% | 18.677% |
| iShares Core DAX® | 1.432% | 2.628% | 12.457% |
| iShares Nasdaq 100 | 1.892% | -0.458% | 1.248% |
| iShares Nikkei 225® | -1.619% | 11.097% | 27.382% |
| iShares S&P 500 | 1.921% | 1.159% | 1.635% |
Comments by Stifel_Nicolaus for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $240.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten
Current prediction by Stifel_Nicolaus for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€249.70
31.03.25
31.03.25
€318.23
31.03.26
31.03.26
14.26%
20.02.26
20.02.26
Stopped prediction by Stifel_Nicolaus for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€346.10
11.12.25
11.12.25
€434.59
11.12.26
11.12.26
-17.57%
20.02.26
20.02.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€387.60
06.10.25
06.10.25
€422.24
06.10.26
06.10.26
-26.39%
20.02.26
20.02.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€228.70
27.06.24
27.06.24
€275.15
27.06.25
27.06.25
20.16%
28.06.25
28.06.25